Search

everythinglearnresearchcommunity

for

Search:↓

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Neurosteroids show promise for treating epilepsy and more research is needed.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.